Replimune Group Inc. Stock Performance
as on June 19, 2026 at 2:16 pm IST
Day's Low
Day's High
$9.90$10.44
2.85%
Downside
2.45%
Upside
52 Week's Low
52 Week's High
$1.50$13.2485.28%
Downside
29.93%
Upside
Replimune Group Inc. share price movements today
- Previous Close
- $10.00
- Open
- $10.25
- Volume
- 1.9M
- Day's Low - High
- $9.90 - $10.44
- 52 Week Low - High
- $1.50 - $13.24
Replimune Group Inc. Historical Returns
- 1 Month Return
- + 116.81 %
- 3 Month Return
- + 47.9 %
- 1 Year Return
- + 7.38 %
- 3 Year Return
- -57.27 %
- 5 Year Return
- -71.21 %
Replimune Group Inc. Stock Fundamentals & Key Indicators
Check Replimune Group Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$825.7M
EPS (TTM)
-3.275
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-318.9M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
-90.88%
Replimune Group Inc. stock Key Stats
Compare market cap, revenue, PE, and other key metrics of Replimune Group Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| BUY | $825.7M | -71.21% | NA | 0.00% | NA |
Stock Returns calculator for Replimune Group Inc. Stock including INR - Dollar returns
The Replimune Group Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Replimune Group Inc. investment value today
Current value as on today
₹1,16,612
Returns
₹16,612
(+16.61%)
Returns from Replimune Group Inc. Stock
₹7,376 (+7.38%)
Dollar Impact
₹9,236 (+9.24%)
Analyst Recommendation on Replimune Group Inc. Stock
Based on 15 analysts
93.33%
Buy
6.67%
Hold
0.00%
Sell
Based on 15 analysts, 93.33% of analysts recommend a 'BUY' rating for Replimune Group Inc.. Average target price of $4.67
Replimune Group Inc. Share Price Target
Get share price movements and forecasts by analysts on Replimune Group Inc..
What analysts predicted
-118.2%DOWNSIDE
Target Price
$4.67
Current Price
$10.19
Analyzed by
15 Analysts
Target
$4.67
Replimune Group Inc. target price $4.67, a slight downside of -118.2% compared to current price of $10.19. According to 15 analysts rating.
Indian Investors' Interest in Replimune Group Inc. Stock
Search interest for Replimune Group Inc. Stock has decreased by -1% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Replimune Group Inc. Quarterly Profit & Loss
All numbers in Millions USD
Replimune Group Inc. Annual Profit & Loss
All numbers in Millions USD
Replimune Group Inc. Quarterly Cash Flow
All numbers in Millions USD
Replimune Group Inc. Annual Cash Flow
All numbers in Millions USD
Replimune Group Inc. News & Key Events
Today's Timeline - 20 October
Mon, 06:49 PM
-Replimune's stock rises 105% after FDA accepts resubmission for RP1 therapy in advanced melanoma, with a decision due by April 2026.
Insights on Replimune Group Inc.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 1 month, REPL stock has moved up by 97.5%
NO EFFECTAgainst Peers
In the last 3 years, Firstsource Solutions Ltd has given 89.0% return, outperforming this stock by 147.1%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 68.64% of holdings in Mar 2026 quarter
- NO EFFECT
Against Peers
In the last 1 year, Regeneron Pharmaceuticals, Inc. Common Stock has given 19.7% return, outperforming this stock by 9.8%
- NO EFFECT
Against Peers
In the last 3 years, Replimune Group, Inc. Common Stock has experienced a drawdown of -56.9%, however Alnylam Pharmaceuticals, Inc. Common Stock resisted the overall trend and outperformed by 35.0%
- NO EFFECT
Against Peers
In the last 1 year, One 97 Communications Ltd has given 25.1% return, outperforming this stock by 85.3%
NEGATIVE IMPACTRetail Holding Down
Retail Investor have decreased holdings from 31.24% to 31.21% in Mar 2026 quarter
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 4 quarters, 2.49 Cr → -13.38 Cr (in ₹), with an average decrease of 392.2% per quarter
- NEGATIVE IMPACT
Price Dip
In the last 6 months, REPL stock has moved down by -44.8%
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 3 quarters, 22.22 Cr → 21.38 Cr (in ₹), with an average decrease of 1.9% per quarter
About Replimune Group Inc.
| Organisation | Replimune Group Inc. |
| Headquarters | 500 Unicorn Park Drive, Woburn, MA, United States, 01801 |
| Industry | Biotechnology |
| CEO | Dr. Sushil Patel Ph.D. |
| E-voting on shares | Click here to vote |
Key Management of Replimune Group Inc.
Name | Title |
|---|---|
Ms. Emily Luisa Hill | Chief Financial Officer |
Dr. Konstantinos Xynos M.B.A., M.D., Ph.D. | Chief Medical Officer |
Mr. Philip Astley-Sparke F.S.A. | Executive Chairman |
Mr. Shawn Glidden J.D. | Senior VP & General Counsel |
Mr. Paul Bullock | Chief Manufacturing Officer & Framingham Site Head |
Ms. Nina Aragam | Senior Vice President of Portfolio Strategy & Program Management |
Dr. Sushil Patel Ph.D. | CEO & Director |
Mr. Andrew Schwendenman | Chief Accounting Officer & Treasurer |
Mr. Camilo Garcia M.A., M.B.A. | Chief Human Resource Officer |
Ms. Carolyn Trott | Senior Vice President of Quality Assurance |
FAQs
What is Replimune Group Inc. share price today?
Replimune Group Inc. share price today is $10.19 as on at the close of the market. Replimune Group Inc. share today touched a day high of $10.44 and a low of $9.9.
What is the 52 week high and 52 week low for Replimune Group Inc. share?
Replimune Group Inc. share touched a 52 week high of $13.24 on and a 52 week low of $1.5 on . Replimune Group Inc. stock price today i.e. is closed at $10.19,which is 23.04% down from its 52 week high and 579.33% up from its 52 week low.
What is Replimune Group Inc.'s market capitalisation today?
Replimune Group Inc. market capitalisation is $0.00T as on .
How to invest in Replimune Group Inc. Stock (REPL) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Replimune Group Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Replimune Group Inc. Shares that will get you 0.1472 shares as per Replimune Group Inc. share price of $10.19 per share as on June 19, 2026 at 8:46 am IST.
What is the minimum amount required to buy Replimune Group Inc. Stock (REPL) from India?
Indian investors can start investing in Replimune Group Inc. (REPL) shares with as little as ₹94.31 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹943.10 in Replimune Group Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Replimune Group Inc. share’s latest price of $10.19 as on June 19, 2026 at 8:46 am IST, you will get 0.9814 shares of Replimune Group Inc.. Learn more about
fractional shares .
What are the returns that Replimune Group Inc. has given to Indian investors in the last 5 years?
Replimune Group Inc. stock has given -71.21% share price returns and 27.56% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?